Literature DB >> 9845286

Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin.

S Ferrari1, M Morbin, E Nobile-Orazio, A Musso, G Tomelleri, L Bertolasi, N Rizzuto, S Monaco.   

Abstract

Increased titers of circulating antisulfatide antibodies are consistently associated with a variety of chronic axonal and demyelinating polyneuropathy syndromes. Previous studies have shown that the pattern of antisulfatide binding to neural tissues correlates with the type of neuropathy. This suggests a possible role for antisulfatide antibodies in inducing peripheral nerve dysfunction, although their exact contribution to the pathogenesis of neuropathy is still unknown. We examined sural nerve biopsy specimens from two patients with sensorimotor and small fiber sensory neuropathy associated with high titers of IgM monoclonal antibodies to sulfatide. Electrophysiological and pathological findings were consistent with predominant demyelination in the patient with sensorimotor involvement, whereas evidence of demyelination was obtained only by teased fiber examination in the other patient. The ultrastructural study disclosed in both cases the presence of myelinated fibers with widely spaced myelin, due to a separation of leaflets of the intraperiod lines. Immunocytochemistry, performed on frozen sections, demonstrated the presence of IgM and complement product C3d bound to myelin sheaths of almost all fibers. Few fibers were immunoreactive for complement components C1q and C5. In addition, the terminal complement complex neoantigen C5b-C9, not associated with S protein, was detected on some myelinated fibers. The results suggest that, at the least in some forms of demyelinating neuropathy associated with antisulfatide antibodies, pathological changes are complement mediated. Our data further confirm previous clinical and experimental observations that complement activation initiates separation of myelin intraperiod lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845286     DOI: 10.1007/s004010050937

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

Review 1.  Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.

Authors:  Jens O Watzlawik; Bharath Wootla; Meghan M Painter; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2013-09       Impact factor: 4.618

Review 2.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Authors:  Michael Pt Lunn; Eduardo Nobile-Orazio
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

3.  Identification of lncRNA expression profile in the spinal cord of mice following spinal nerve ligation-induced neuropathic pain.

Authors:  Bao-Chun Jiang; Wen-Xing Sun; Li-Na He; De-Li Cao; Zhi-Jun Zhang; Yong-Jing Gao
Journal:  Mol Pain       Date:  2015-07-17       Impact factor: 3.395

4.  Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.

Authors:  Bianca T A de Greef; Margot Geerts; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Trials       Date:  2016-07-20       Impact factor: 2.279

5.  Differential binding patterns of anti-sulfatide antibodies to glial membranes.

Authors:  Gavin R Meehan; Rhona McGonigal; Madeleine E Cunningham; Yuzhong Wang; Jennifer A Barrie; Susan K Halstead; Dawn Gourlay; Denggao Yao; Hugh J Willison
Journal:  J Neuroimmunol       Date:  2018-07-09       Impact factor: 3.478

6.  Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.

Authors:  Margot Geerts; Bianca T A de Greef; Maurice Sopacua; Sander M J van Kuijk; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies
Journal:  Neurology       Date:  2021-03-25       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.